| |
|
|
|
Xtalks, Online
2024-03-05
The need for rapid, accessible and portable infectious disease diagnostics for seasonal respiratory diseases like influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 is critical to saving lives. Join an informative webinar focused on in vitro diagnostic development to meet this need, ranging from assay design, the use of bioinformatics in identifying emerging pathogens and optimizing assays, and securing the necessary regulatory approvals that support market access.
Advancing novel, highly sensitive diagnostic assays for infectious diseases requires extensive research and development experience. In a post-pandemic world, as consumers expect these technologies available at point-of-care, this experience has never been more valuable. Because the symptoms of diseases like influenza, RSV and SARS-CoV-2 can be very similar, there is significant benefit in a single diagnostic that tests for the presence of multiple respiratory pathogens.
Read more...
Join this webinar to learn how to effectively take an infectious disease diagnostic assay from initial design stages through regulatory approvals that support market access.
Keywords: Diagnostic Tests, RSV, Diagnostic Assays, COVID-19 Diagnostics, Diagnostic Testing, COVID-19, In Vitro Diagnostics, Public Health, Diagnostics, Diagnostic, In-Vitro Diagnostic Devices, Respiratory Disease, Respiratory Virus, CRO, Infectious Disease, Diagnostic Test, Diagnostic Device, Influenza
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Jennifer Stone, MS, Principal Scientist, MRIGlobal
Joe Russell, PhD, Principal Scientist, Group Leader — Applied Biology & Bioinformatics, MRIGlobal
Yvette Girard, MPH, PhD, Principal Science Advisor, MRIGlobal
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-03-05
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|